Skip to main content
Signal8

Zura Bio Ltd (ZURA) Form 8-K — Jun 18, 2026

$ZURAForm 8-KItems 5.02, 5.07, 9.01Filed Jun 18, 2026, 8:00 AM ET0001104659-26-075826Original filing

Zura Bio Limited shareholders approved the Amended and Restated 2023 Equity Incentive Plan during the Annual General Meeting held on June 17, 2026. The plan reserves 9,594,213 Ordinary Shares and includes an evergreen provision to increase the reserve by 5% annually from 2027 through 2029 to facilitate talent retention. Shareholders also ratified the appointment of WithumSmith+Brown, PC as the independent auditor for the fiscal year ending December 31, 2026, and elected eight directors to the Board. The voting results indicated approval for all director nominees and the auditor, with the incentive plan approval receiving 38.8 million votes in favor against 17.4 million votes opposed.

Key figures

Plan Votes For
38850373
Chair Monthly Pay
25000
Plan Votes Abstain
26663
Plan Votes Against
17403607
Director Comp Limit
750000
Aggregate Share Limit
9594213
Evergreen Percentage
5.0%
Director Comp Limit First Year
1000000

Price after filing

1 day: 0.0%7 days: +21.1%30 days: +40.0%

Close on the filing date to close N calendar days later (from $3.75). Historical, not a forecast.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.